Palisade Bio, Inc.
PALI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,438 | -$12,300 | -$14,260 | -$26,616 |
| Dep. & Amort. | $3 | $4 | $3 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $652 | $624 | $1,032 | $1,891 |
| Change in WC | $1,391 | $400 | $1,250 | -$4,756 |
| Other Non-Cash | $199 | $139 | -$1,385 | $14,706 |
| Operating Cash Flow | -$12,193 | -$11,133 | -$13,360 | -$14,773 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$4 | -$10 | $0 |
| Net Acquisitions | $0 | $0 | $0 | -$54 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$4 | -$10 | -$54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$426 | -$391 | -$790 | -$183 |
| Stock Issued | $8,435 | $9,419 | $14,401 | $5,209 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,573 | $2,158 | $1,647 | $19,583 |
| Financing Cash Flow | $9,582 | $11,186 | $15,258 | $24,609 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,611 | $49 | $1,888 | $9,782 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,458 | $12,409 | $10,521 | $739 |
| End Cash | $9,847 | $12,458 | $12,409 | $10,521 |
| Free Cash Flow | -$12,193 | -$11,137 | -$13,370 | -$14,773 |